Adjusted EBITDAC Margin guidance for full year 2024 is between 32.0% – 32.5%.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RYAN:
- Ryan Specialty reports Q3 adjusted EPS 41c, consensus 42c
- Ryan Specialty price target raised to $84 from $75 at BofA
- BMO upgrades Ryan Specialty to Outperform on EBITDA growth runway
- Ryan Specialty upgraded to Outperform from Market Perform at BMO Capital
- Ryan Specialty Group Plans Debt Refinancing and Offering